{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:17:53Z","timestamp":1757621873948,"version":"3.44.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82070962"],"award-info":[{"award-number":["No. 82070962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04286-3","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:24:18Z","timestamp":1754580258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between serum neuropeptide Y levels and anxiety, depression, and quality of life in Chinese patients with primary glaucoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Kaihui","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"11","key":"4286_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081\u201390.","journal-title":"Ophthalmology"},{"issue":"11","key":"4286_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/IJG.0000000000000761","volume":"26","author":"Y Otori","year":"2017","unstructured":"Otori Y, Takahashi G, Urashima M, Kuwayama Y. Evaluating the quality of life of glaucoma patients using the State-Trait anxiety inventory. J Glaucoma. 2017;26(11):1025\u20139.","journal-title":"J Glaucoma"},{"issue":"5","key":"4286_CR3","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1097\/IJG.0000000000000025","volume":"24","author":"X Kong","year":"2015","unstructured":"Kong X, Yan M, Sun X, Xiao Z. Anxiety and depression are more prevalent in primary angle closure glaucoma than in primary Open-Angle glaucoma. J Glaucoma. 2015;24(5):e57\u201363.","journal-title":"J Glaucoma"},{"issue":"1","key":"4286_CR4","doi-asserted-by":"publisher","first-page":"11671","DOI":"10.1038\/s41598-018-29489-1","volume":"8","author":"D Zhang","year":"2018","unstructured":"Zhang D, Fan Z, Gao X, Huang W, Yang Q, Li Z, Lin M, Xiao H, Ge J. Illness uncertainty, anxiety and depression in Chinese patients with glaucoma or cataract. Sci Rep. 2018;8(1):11671.","journal-title":"Sci Rep"},{"issue":"1","key":"4286_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpsychores.2013.03.005","volume":"75","author":"C Zhou","year":"2013","unstructured":"Zhou C, Qian S, Wu P, Qiu C. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical, and self-reported correlates. J Psychosom Res. 2013;75(1):75\u201382.","journal-title":"J Psychosom Res"},{"issue":"1","key":"4286_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1523\/JNEUROSCI.2599-16.2016","volume":"37","author":"Q Li","year":"2017","unstructured":"Li Q, Bartley AF, Dobrunz LE. Endogenously released neuropeptide Y suppresses hippocampal Short-Term facilitation and is impaired by Stress-Induced anxiety. J Neurosci. 2017;37(1):23\u201337.","journal-title":"J Neurosci"},{"issue":"4","key":"4286_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","volume":"38","author":"M Heilig","year":"2004","unstructured":"Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides. 2004;38(4):213\u201324.","journal-title":"Neuropeptides"},{"issue":"4","key":"4286_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.alcohol.2011.11.009","volume":"46","author":"NW Gilpin","year":"2012","unstructured":"Gilpin NW. Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors. Alcohol. 2012;46(4):329\u201337.","journal-title":"Alcohol"},{"key":"4286_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","volume":"55","author":"F Reichmann","year":"2016","unstructured":"Reichmann F, Holzer P. Neuropeptide Y: A stressful review. Neuropeptides. 2016;55:99\u2013109.","journal-title":"Neuropeptides"},{"key":"4286_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fendo.2017.00178","volume":"8","author":"A Thorsell","year":"2017","unstructured":"Thorsell A, Math\u00e9 AA. Neuropeptide Y in alcohol addiction and affective disorders. Front Endocrinol (Lausanne). 2017;8:178.","journal-title":"Front Endocrinol (Lausanne)"},{"doi-asserted-by":"crossref","unstructured":"Kupcova I, Danisovic L, Grgac I, Harsanyi S. Anxiety and depression: what do we know of neuropeptides?? Behav Sci (Basel) 2022, 12(8).","key":"4286_CR11","DOI":"10.3390\/bs12080262"},{"issue":"6","key":"4286_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.peptides.2011.03.023","volume":"32","author":"F Gelfo","year":"2011","unstructured":"Gelfo F, De Bartolo P, Tirassa P, Croce N, Caltagirone C, Petrosini L, Angelucci F. Intraperitoneal injection of neuropeptide Y (NPY) alters neurotrophin rat hypothalamic levels: implications for NPY potential role in stress-related disorders. Peptides. 2011;32(6):1320\u20133.","journal-title":"Peptides"},{"key":"4286_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.psyneuen.2013.10.017","volume":"40","author":"R Sah","year":"2014","unstructured":"Sah R, Ekhator NN, Jefferson-Wilson L, Horn PS, Geracioti TD Jr. Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder. Psychoneuroendocrinology. 2014;40:277\u201383.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"4286_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0035-1565241","volume":"49","author":"S Ozsoy","year":"2016","unstructured":"Ozsoy S, Olguner Eker O, Abdulrezzak U. The effects of antidepressants on neuropeptide Y in patients with depression and anxiety. Pharmacopsychiatry. 2016;49(1):26\u201331.","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"4286_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/mds.26885","volume":"32","author":"P Martinez-Martin","year":"2017","unstructured":"Martinez-Martin P. What is quality of life and how do we measure it? Relevance to parkinson\u2019s disease and movement disorders. Mov Disord. 2017;32(3):382\u201392.","journal-title":"Mov Disord"},{"issue":"3","key":"4286_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0161-6420(98)93043-3","volume":"105","author":"MB Sherwood","year":"1998","unstructured":"Sherwood MB, Garcia-Siekavizza A, Meltzer MI, Hebert A, Burns AF, McGorray S. Glaucoma\u2019s impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology. 1998;105(3):561\u20136.","journal-title":"Ophthalmology"},{"issue":"7","key":"4286_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0008-4182(01)80082-X","volume":"36","author":"F Montemayor","year":"2001","unstructured":"Montemayor F, Sibley LM, Courtright P, Mikelberg FS. Contribution of multiple glaucoma medications to visual function and quality of life in patients with glaucoma. Can J Ophthalmol. 2001;36(7):385\u201390.","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"4286_CR18","first-page":"88","volume":"45","author":"SX Xi","year":"2009","unstructured":"Xi SX, Guo WY. [Progress of research on quality of life of glaucoma patients]. Zhonghua Yan Ke Za Zhi. 2009;45(1):88\u201392.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"11","key":"4286_CR19","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/archopht.1997.01100160617016","volume":"115","author":"RK Parrish","year":"1997","unstructured":"Parrish RK 2nd, Gedde SJ, Scott IU, Feuer WJ, Schiffman JC, Mangione CM, Montenegro-Piniella A. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115(11):1447\u201355.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"4286_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ophtha.2013.09.043","volume":"121","author":"M Qiu","year":"2014","unstructured":"Qiu M, Wang SY, Singh K, Lin SC. Association between visual field defects and quality of life in the united States. Ophthalmology. 2014;121(3):733\u201340.","journal-title":"Ophthalmology"},{"key":"4286_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/PRBM.S241192","volume":"13","author":"M Saei Ghare Naz","year":"2020","unstructured":"Saei Ghare Naz M, Ramezani Tehrani F, Behroozi Lak T, Mohammadzadeh F, Nasiri M, Kholosi Badr F, Ozgoli G. Quality of life and emotional States of depression, anxiety and stress in adolescents with polycystic ovary syndrome: A Cross-Sectional study. Psychol Res Behav Manag. 2020;13:203\u20139.","journal-title":"Psychol Res Behav Manag"},{"issue":"1","key":"4286_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.15386\/mpr-1502","volume":"93","author":"IV Papathanasiou","year":"2020","unstructured":"Papathanasiou IV, Kelepouris K, Valari C, Papagiannis D, Tzavella F, Kourkouta L, Tsaras K, Fradelos EC. Depression, anxiety and stress among patients with hematological malignancies and the association with quality of life: a cross-sectional study. Med Pharm Rep. 2020;93(1):62\u20138.","journal-title":"Med Pharm Rep"},{"issue":"2","key":"4286_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/bjo.86.2.238","volume":"86","author":"PJ Foster","year":"2002","unstructured":"Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238\u201342.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"4286_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0033-3182(71)71479-0","volume":"12","author":"WW Zung","year":"1971","unstructured":"Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371\u20139.","journal-title":"Psychosomatics"},{"key":"4286_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","volume":"12","author":"WW Zung","year":"1965","unstructured":"Zung WW. A SELF-RATING DEPRESSION SCALE. Arch Gen Psychiatry. 1965;12:63\u201370.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"4286_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5455\/msm.2019.31.268-272","volume":"31","author":"A Papazisis","year":"2019","unstructured":"Papazisis A, Koreli A, Misouridou E. Heavy smoking is associated with low depression and stress: a smokers\u2019 paradox in cardiovascular disease?? Mater Sociomed. 2019;31(4):268\u201372.","journal-title":"Mater Sociomed"},{"issue":"5","key":"4286_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.janxdis.2005.08.002","volume":"20","author":"BO Olatunji","year":"2006","unstructured":"Olatunji BO, Deacon BJ, Abramowitz JS, Tolin DF. Dimensionality of somatic complaints: factor structure and psychometric properties of the Self-Rating anxiety scale. J Anxiety Disord. 2006;20(5):543\u201361.","journal-title":"J Anxiety Disord"},{"issue":"12","key":"4286_CR28","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.addbeh.2008.06.001","volume":"33","author":"VC Chen","year":"2008","unstructured":"Chen VC, Chen H, Lin TY, Chou HH, Lai TJ, Ferri CP, Gossop M. Severity of heroin dependence in taiwan: reliability and validity of the Chinese version of the severity of dependence scale (SDS[Ch]). Addict Behav. 2008;33(12):1590\u20133.","journal-title":"Addict Behav"},{"key":"4286_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-244X-1-6","volume":"1","author":"KN Fountoulakis","year":"2001","unstructured":"Fountoulakis KN, lacovides A, Samolis S, Kleanthous S, Kaprinis SG, St Kaprinis G, Bech P. Reliability, validity and psychometric properties of the Greek translation of the Zung depression rating scale. BMC Psychiatry. 2001;1:6.","journal-title":"BMC Psychiatry"},{"key":"4286_CR30","first-page":"202","volume":"7","author":"X Wang","year":"1993","unstructured":"Wang X. Self-rating anxiety scales. Chin Mental Health J. 1993;7:202\u20134.","journal-title":"Chin Mental Health J"},{"key":"4286_CR31","first-page":"160","volume":"7","author":"X Wang","year":"1993","unstructured":"Wang X. Self-rating depression scales. Chin Mental Health J. 1993;7:160\u20131.","journal-title":"Chin Mental Health J"},{"issue":"1","key":"4286_CR32","doi-asserted-by":"publisher","first-page":"e000177","DOI":"10.1136\/rmdopen-2015-000177","volume":"2","author":"S van Genderen","year":"2016","unstructured":"van Genderen S, Plasqui G, Lacaille D, Arends S, van Gaalen F, van der Heijde D, Heuft L, Keszei A, Luime J, Spoorenberg A, et al. Social role participation questionnaire for patients with ankylosing spondylitis: translation into dutch, reliability and construct validity. RMD Open. 2016;2(1):e000177.","journal-title":"RMD Open"},{"issue":"2","key":"4286_CR33","first-page":"109","volume":"36","author":"L Li","year":"2002","unstructured":"Li L, Wang H, Shen Y. Development and psychometric tests of a Chinese version of the SF-36 health survey scales. Zhonghua Yu Fang Yi Xue Za Zhi. 2002;36(2):109\u201313.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"7","key":"4286_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/IJG.0000000000000393","volume":"25","author":"NC Lim","year":"2016","unstructured":"Lim NC, Fan CH, Yong MK, Wong EP, Yip LW. Assessment of depression, anxiety, and quality of life in Singaporean patients with glaucoma. J Glaucoma. 2016;25(7):605\u201312.","journal-title":"J Glaucoma"},{"issue":"2","key":"4286_CR35","doi-asserted-by":"publisher","first-page":"e046194","DOI":"10.1136\/bmjopen-2020-046194","volume":"12","author":"N Wu","year":"2022","unstructured":"Wu N, Kong X, Sun X. Anxiety and depression in Chinese patients with glaucoma and its correlations with vision-related quality of life and visual function indices: a cross-sectional study. BMJ Open. 2022;12(2):e046194.","journal-title":"BMJ Open"},{"issue":"7","key":"4286_CR36","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/IJG.0b013e31816299d4","volume":"17","author":"F Mabuchi","year":"2008","unstructured":"Mabuchi F, Yoshimura K, Kashiwagi K, Shioe K, Yamagata Z, Kanba S, Iijima H, Tsukahara S. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma. 2008;17(7):552\u20137.","journal-title":"J Glaucoma"},{"issue":"3","key":"4286_CR37","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ophtha.2014.09.030","volume":"122","author":"EW Chan","year":"2015","unstructured":"Chan EW, Chiang PP, Liao J, Rees G, Wong TY, Lam JS, Aung T, Lamoureux E. Glaucoma and associated visual acuity and field loss significantly affect glaucoma-specific psychosocial functioning. Ophthalmology. 2015;122(3):494\u2013501.","journal-title":"Ophthalmology"},{"issue":"3","key":"4286_CR38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ajo.2012.03.039","volume":"154","author":"SY Wang","year":"2012","unstructured":"Wang SY, Singh K, Lin SC. Prevalence and predictors of depression among participants with glaucoma in a nationally representative population sample. Am J Ophthalmol. 2012;154(3):436\u2013e444432.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"4286_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.62641\/aep.v52i3.1561","volume":"52","author":"J Yin","year":"2024","unstructured":"Yin J, Li H, Guo N. Prevalence of depression and anxiety disorders in patients with glaucoma: A systematic review and Meta-Analysis based on Cross-Sectional surveys. Actas Esp Psiquiatr. 2024;52(3):325\u201333.","journal-title":"Actas Esp Psiquiatr"},{"issue":"2","key":"4286_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.4103\/ijo.IJO_1676_22","volume":"71","author":"UPS Usgaonkar","year":"2023","unstructured":"Usgaonkar UPS, Naik R, Shetty A. The economic burden of glaucoma on patients. Indian J Ophthalmol. 2023;71(2):560\u20136.","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"4286_CR41","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archopht.126.6.849","volume":"126","author":"T Bramley","year":"2008","unstructured":"Bramley T, Peeples P, Walt JG, Juhasz M, Hansen JE. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch Ophthalmol. 2008;126(6):849\u201356.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"4286_CR42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1136\/bjo.2005.067355","volume":"89","author":"CE Traverso","year":"2005","unstructured":"Traverso CE, Walt JG, Kelly SP, Hommer AH, Bron AM, Denis P, Nordmann JP, Renard JP, Bayer A, Grehn F, et al. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol. 2005;89(10):1245\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"4286_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/IJG.0b013e3180575202","volume":"16","author":"PP Lee","year":"2007","unstructured":"Lee PP, Kelly SP, Mills RP, Traverso CE, Walt JG, Doyle JJ, Katz LM, Siegartel LR. Glaucoma in the united States and europe: predicting costs and surgical rates based upon stage of disease. J Glaucoma. 2007;16(5):471\u20138.","journal-title":"J Glaucoma"},{"issue":"9","key":"4286_CR44","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2174\/1570159X19666210906120302","volume":"20","author":"S Pain","year":"2022","unstructured":"Pain S, Brot S, Gaillard A. Neuroprotective effects of neuropeptide Y against neurodegenerative disease. Curr Neuropharmacol. 2022;20(9):1717\u201325.","journal-title":"Curr Neuropharmacol"},{"key":"4286_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pneurobio.2013.10.002","volume":"112","author":"A Santos-Carvalho","year":"2014","unstructured":"Santos-Carvalho A, \u00c1lvaro AR, Martins J, Ambr\u00f3sio AF, Cavadas C. Emerging novel roles of neuropeptide Y in the retina: from neuromodulation to neuroprotection. Prog Neurobiol. 2014;112:70\u20139.","journal-title":"Prog Neurobiol"},{"issue":"5","key":"4286_CR46","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1111\/j.1471-4159.2009.06079.x","volume":"109","author":"AR Alvaro","year":"2009","unstructured":"Alvaro AR, Rosmaninho-Salgado J, Ambr\u00f3sio AF, Cavadas C. Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors. J Neurochem. 2009;109(5):1508\u201315.","journal-title":"J Neurochem"},{"key":"4286_CR47","doi-asserted-by":"publisher","first-page":"110349","DOI":"10.1016\/j.pnpbp.2021.110349","volume":"111","author":"H Domin","year":"2021","unstructured":"Domin H. Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: evidence from preclinical studies. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110349.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04286-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:45:44Z","timestamp":1757346344000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04286-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4286"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04286-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"type":"electronic","value":"1471-2415"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval was obtained from the ethics committee of the Affiliated Hospital of Southwest Medical University (KY2019084). This study was carried out in accordance with the declaration of Helsinki, and written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"448"}}